Acta Med. 2011, 54: 137-143
https://doi.org/10.14712/18059694.2016.37
Use of Bio-Degradable Stents for the Treatment of Refractory Benign Gastrointestinal Stenoses
References
1. 2008) Endoscopic stenting – where we are now and where can we go? World J Gastroenterol 14: 3798–3803.
< MT, Byrne MF (https://doi.org/10.3748/wjg.14.3798>
<PubMed>
2. 2000) Plastic prosthesis in the palliation of small bowel stenosis secondary to recurrent gastric cancer: initial cost saving. Gastrointest Endoscopy 52: 571–573.
< M, Hajiro K, Takakuwa H, Nishio A, Kusumi F (https://doi.org/10.1067/mge.2000.108924>
3. 2001). Knitted nitinol stent insertion for various intestinal stenoses with a modified delivery system. Gastrointest Endoscopy 54: 364–367.
< I, Ukita T, Inone H, Yoshida M, Igarashi Y, Sakai Y (https://doi.org/10.1067/mge.2001.116882>
4. 2001) Placement of additional stent for recanalizing procedure of occluded jejunal stent. Gastrointest Endoscopy 54: 394–397.
< A, Kakemura T, Maetani I, Igarashi Y, Sakai Y (https://doi.org/10.1067/mge.2001.116625>
5. 2001) Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction. Gastrointest Endoscopy 53: 329–332.
< HB, Jacobson BC, Saltzman JR, Johannes RS, Bounds BC, Lee JH, Shields SJ, Ruymann FW, Van Dam J, Carr-Locke DL (https://doi.org/10.1016/S0016-5107(01)70407-5>
6. 2003) Enteral self-expandable stents. Gastrointest Endoscopy 58: 421–433.
< TH, Harewood GC (https://doi.org/10.1067/S0016-5107(03)00023-3>
7. 2006) Enteral stent placement by double balloon enteroscopy for palliation of malignant small bowel obstruction. Gastrointest Endoscopy 64: 835–837.
< AS, Semrad C, Waxman I, Dye C (https://doi.org/10.1016/j.gie.2006.03.001>
8. 2010) Spiral-enteroscopy-assisted enteral stent placement for palliation of malignant small-bowel obstruction. Gastrointest Endoscopy 71: 422–425.
< AM, Chandrasekhara V, Shin EJ, Okolo PI (https://doi.org/10.1016/j.gie.2009.07.024>
9. 1998) Self-expanding metal stents in the palliation of small bowel stenosis secondary to recurrent gastric cancer. Gastrointest Endoscopy 47: 286–290.
< J, Bliss R, Richardson DL, Griffin SM (https://doi.org/10.1016/S0016-5107(98)70328-1>
10. 2008) Interventional double balloon endoscopy for Crohn’s, gastrointestinal bleeding, and foreign body extraction. Tech Gastrointest Endoscopy 10: 101–106.
< S, Kopacova M, Tacheci I, Bures J (https://doi.org/10.1016/j.tgie.2008.03.002>
11. 2006) Enteral stents. Gastrointest Endosc 63: 920–926.
< W, Chuttani R, Croffie J, DiSario J, Liu J, Mishkin DS, Shah R, Somogyi L, Petersen BT (https://doi.org/10.1016/j.gie.2006.01.015>
12. 2006) Double-balloon endoscopy for the diagnosis and treatment of small intestinal disease. Best Pract Res Clin Gastroenterol 20: 179–194.
< H, Yamamoto H (https://doi.org/10.1016/j.bpg.2005.09.004>
13. 2004) Clinical outcomes of doubleballoon endoscopy for the diagnosis and treatment of small-intestinal disease. Clin Gastroenterol Hepatol 2: 1010–1016.
< H, Kita H, Sunada K, Hayashi Y, Sato H, Yano T, Iwamoto M, Sekine Y, Miyata T, Kuno A, Ajibe H, Ido K, Sugano K (https://doi.org/10.1016/S1542-3565(04)00453-7>
14. 2005) Terminal ileal stricture in Crohn’s disease: treatment using a metallic enteral endoprosthesis. Dis Colon Rectum 48: 1081–1085.
< SJ, Foley E, Lawrence C, Rockoff T, Shaffer HA, Yeaton P (https://doi.org/10.1007/s10350-004-0865-8>
15. 2008) Enteroscopy. Best Pract Res Clin Gastroenterol 22: 789–811.
< K, Bellutti M, Fry LC, Malfertheiner P (https://doi.org/10.1016/j.bpg.2008.05.005>
16. 2008) Biodegradable pancreatic stents: are they a disappearing wonder? Gastrointest Endosc 67: 1113–1115.
< DK, Rana SS (https://doi.org/10.1016/j.gie.2007.12.036>
17. 2001) Bioabsorbable stents for gastrointestinal endoscopy. Tech Gastrointest Endoscopy 3: 120–125.
< ML (https://doi.org/10.1053/tgie.2001.22150>
18. 2007) Endoscopic therapy of benign biliary strictures. World J Gastroenterol 13: 3531–3539.
< JR, Draganov PV (https://doi.org/10.3748/wjg.v13.i26.3531>
<PubMed>
19. 2009) Chitosan glycerophosphate-based semirigid dexamethasone eluting biodegradable stent. Am J Rhinol Allergy 23: 76–79.
< BS, Paulson DP, O’Malley BW, Li D, Palmer JN, Chiu AG, Cohen NA (https://doi.org/10.2500/ajra.2009.23.3268>
20. 2008) Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system. JACC Cardiovasc Interv 1: 545–551.
< JR, Abizaid A, Costa R, Feres F, Tanajura LF, Abizaid A, Mattos LA, Staico R, Siqueira D, Sousa AG, Bonan R, Sousa JE (https://doi.org/10.1016/j.jcin.2008.07.003>
21. 2009) Tailored drug release from biodegradable stent coatings based on hybrid polyurethanes. J Control Release 137: 224–233.
< O, Knight PT, Mather PT (https://doi.org/10.1016/j.jconrel.2009.04.016>
22. 2010) Degradable metallic biomaterials: design and development of Fe-Mn alloys for stents. J Biomed Mater Res A 93: 1–11.
H, Dubé D, Mantovani D (
23. 2008) Bioabsorbable drug-eluting stents: the future of coronary angioplasty? Nat Clin Pract Cardiovasc Med 5: 598–599.
< C, Moreno R (https://doi.org/10.1038/ncpcardio1306>
24. 2007) Usefulness of biodegradable stents constructed of polyl- lactic acid monofilaments in patients with benign esophageal stenosis. World J Gastroenterol 13: 3977–3980.
< Y, Tanaka T, Andoh A, Minematsu H, Hata K, Tsujikawa T, Nitta N, Murata K, Fujiyama Y (https://doi.org/10.3748/wjg.v13.i29.3977>
<PubMed>
25. 2009) Advances in stent drug delivery: the future in bioabsorbable stents. Expert Opin Drug Deliv 6:113–126.
< JJ, Onuma Y, Serruys PW (https://doi.org/10.1517/17425240802668495>
26. 2009) Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in “real-world” practice: 18-month clinical and 9-month angiographic outcomes. JACC Cardiovasc Interv 2: 303–309.
< Y, Jing Q, Xu B, Yang L, Liu H, Shang X, Jiang T, Li Z, Zhang H, Li H, Qiu J, Liu Y, Li Y, Chen X, Gao R and CREATE (Multi-center registry of excel biodegradable polymer drug-eluting stents) investigators (https://doi.org/10.1016/j.jcin.2008.12.013>
27. 2009) MAHOROBA, first-in-man study: 6-month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenoses. Eur Heart J 30: 1477–1485.
< Y, Serruys P, den Heijer P, Joesoef KS, Duckers H, Regar E, Kukreja N, Tanimoto S, Garcia-Garcia HM, van Beusekom H, van der Giessen W, Nishide T (https://doi.org/10.1093/eurheartj/ehp127>
28. 2008) Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 372: 1163–1173.
< S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Davies S, van Geuns RJ, Eerdmans P, van Es GA, Meier B, Jümi P (https://doi.org/10.1016/S0140-6736(08)61244-1>
29. 2008) Fully biodegradable coronary stents: progress to date. Am J Cardiovasc Drugs 8: 305–314.
< S, Serruys PW (https://doi.org/10.2165/00129784-200808050-00003>
30. 2003) In vivo evaluation of a new bioabsorbable selfexpanding biliary stent. Gastrointest Endoscopy 58: 777–784.
< G, Cope C, Shah J, Martin T, Carty A, Habecker P, Kaufmann C, Clerc C, Nuutinen J-P, Törmälä P (https://doi.org/10.1016/S0016-5107(03)02016-9>
31. 2006) Study of biodegradable and self-expandable PLLA helical biliary stent in vivo and in vitro. J Mater Sci Mater Med 17: 611–617.
< B, Wang J, Zhu N, Meng QY, Cui FZ, Xu YX (https://doi.org/10.1007/s10856-006-9223-9>
32. 2007) A novel biodegradable biliary stent in the endoscopic treatment of cystic-duct leakage after cholecystectomy. Gastrointest Endosc 65: 1063–1068.
< J, Nordback I, Mikkonen J, Kärkkäinen P, Sand J (https://doi.org/10.1016/j.gie.2006.11.059>
33. 2008) A novel biodegradable pancreatic stent for human pancreatic applications: a preclinical safety study in a large animal model. Gastrointest Endosc 67: 1106–1112.
< J, Lämsä T, Nordback I, Mikkonen J, Sand J (https://doi.org/10.1016/j.gie.2007.10.013>
34. 2006) Biocompatibility of a new bioabsorbable radiopaque stent material (BaSO4 containing poly-L,D-lactide) in the rat pancreas. Pancreatology 6: 301–305.
< T, Jin H, Mikkonen J, Laukkarinen J, Sand J, Nordback I (https://doi.org/10.1159/000092772>
35. 2000) A new biodegradable stent for the pancreaticojejunal anastomosis after pancreaticoduodenal resection: in vitro examination and pilot experiences in humans. Pancreas 21: 14–21.
< M, Sand J, Harmoinen A, Kainulainen H, Välimaa T, Törmälä P, Nordback I (https://doi.org/10.1097/00006676-200007000-00047>
36. 1997) Management of a refractory benign esophageal stricture with a new biodegradable stent. Gastrointest Endosc 45: 179–182.
< SW, Fleischer DE (https://doi.org/10.1016/S0016-5107(97)70244-X>
37. 1996) A new biodegradable and self-expandable stent for benign esophageal strictures. Gastrointest Endosc 43: 294.
< E, Fiorini A, Ratan Y, Keter D, Loshakove A, Globerman O, Beyar M (https://doi.org/10.1016/S0016-5107(96)80017-4>
38. 2006) Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial. Digestion 74: 199–205.
< T, Takahashi M, Nitta N, Furukawa A, Andoh A, Saito Y, Fujiyama Y, Murata K (https://doi.org/10.1159/000100504>
39. 2008) Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci 53: 330–333.
< Y, Tanaka T, Andoh A, Minematsu H, Hata K, Tsujikawa T, Nitta N, Murata K, Fujiyama Y (https://doi.org/10.1007/s10620-007-9873-6>
40. 2009) Bio-degradable stents – new approach to the treatment of caustic stenoses in children. Folia Gastroenterol Hepatol 7: 30–34. Available from http://www.pro-folia.org.
OV, Lazyuk II, Averin V (
41. 2009) Biodegradable stents in refractory benign oesophageal strictures – first report of 4 patients from UK. Gastrointest Endoscopy 69: AB254–AB255.
< A, Topping JH, Johns E, O’Neill D (https://doi.org/10.1016/j.gie.2009.03.655>
42. 2010) Woven polydioxanone biodegradable stents: a new treatment option for benign and malignant oesophageal strictures. Eur Radiol 20: 1069–1072.
< SM, Williams LR, Senger C, Wilbraham L, Laasch HU (https://doi.org/10.1007/s00330-009-1662-5>
43. 2009) Benign refractory esophageal strictures: preliminary results from the BEST (Biodegradable Esophageal STent) study. Gastrointest Endoscopy 69: AB123.
< A, Vleggaar F, Carlino A, Van Boeckel PG, Romeo F, Siersema PD (https://doi.org/10.1016/j.gie.2009.03.137>
44. 2010) Management of benign intrahepatic bile duct strictures: initial experience with polydioxanone biodegradable stents. Endoscopy 42 Suppl 2: E89–90.
< J, Bruha R, Horak L, Zadorova Z, Dosedel J, Laasch HU (https://doi.org/10.1055/s-0029-1243880>
45. 2011) Biodegradable polydioxanone stents: a new option for therapy-resistant anastomotic strictures of the colon. Eur Radiol. 21: 1956–61.
< V, Horak L, Hnanicek J, Malek J, Laasch HU (https://doi.org/10.1007/s00330-011-2131-5>
46. 2009) Intestinal biodegradable stents. Initial experience in the Czech Republic. Folia Gastroenterol Hepatol 7: 7–11. Available from http://www.pro-folia.org.
S, Kopacova M, Bartova J, Bures J (
47. England R (2008) Implant of SX-ELLA BD biodegradable stent in patient with post radiotherapy benign oesophageal stricture. BD Clinical Bulletin A44pp. UK Medical Limited: Sheffield, 2008. Available from: http://www.ukmedical.com.
48. 2011) Biodegradable stents for the treatment of benign stenoses of the small and large intestines. Endoscopy 43: 911–917.
< S, Kopacova M, Brozik J, Bures J (https://doi.org/10.1055/s-0030-1256405>
49. 2007) Intraoperative enteroscopy. Ten years’ experience at a single tertiary center. Surg Endoscopy 21: 1111–1116.
< M, Bures J, Vykouril L, Hladik P, Simkovic D, Jon B, Ferko A, Tacheci I, Rejchrt S (https://doi.org/10.1007/s00464-006-9052-4>
50. 2007) Hyperamylasemia of uncertain significance associated with oral double-balloon enteroscopy. Gastrointest Endoscopy 66: 1133–1138.
< M, Rejchrt S, Tacheci I, Bures J (https://doi.org/10.1016/j.gie.2007.03.1085>
51. 2004) Biodegradation of absorbable sutures in body fluids and pH buffers. Eur Surg Res 36: 376–385.
< S, Rewerk S, Kaess M, Weiss C, Dorn-Beinecke A, Post S (https://doi.org/10.1159/000081648>
52. 2006) Recent developments in biodegradable synthetic polymers. Biotechnol Annu Rev 12: 301–347.
< P, Mayadunne R, Adhikari R (https://doi.org/10.1016/S1387-2656(06)12009-8>